Reaction
Visceral Leishmaniasis reporting signals
As of the last recalculation, Visceral Leishmaniasis appears in 706 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 115.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 46 | 115.7 | 116.1 |
| Mycophenilic Acid | 32 | 47.6 | 47.7 |
| Lamivudine Oral | 32 | 39.0 | 39.1 |
| Adalimumab-Fkjp | 54 | 37.1 | 37.2 |
| Adalimumab-Aaty | 54 | 36.3 | 36.4 |
| Lamivudine | 33 | 33.0 | 33.0 |
| Adalimumab-Adaz | 54 | 32.6 | 32.6 |
| Tacrolimus Ointment 0.1% | 115 | 32.3 | 32.4 |
| Tacrolimus Extended-Release Capsules | 115 | 32.2 | 32.3 |
| Mycophenolic Acid | 32 | 30.8 | 30.9 |
| Pemetrexed | 21 | 29.7 | 29.8 |
| Efavirenz | 11 | 29.5 | 29.6 |
| Mycophenolate Mofetil | 107 | 27.2 | 27.2 |
| Mycophenolate Mofetil Hydrochloride | 107 | 27.1 | 27.2 |
| Tacrolimus | 120 | 27.0 | 27.0 |
| Daratumumab | 34 | 26.3 | 26.3 |
| Lopinavir And Ritonavir | 11 | 24.3 | 24.3 |
| Tenofovir Disoproxil Fumarate Tablets | 7 | 24.1 | 24.1 |
| Nevirapine | 6 | 19.8 | 19.8 |
| Daptomycin | 6 | 19.3 | 19.3 |
| Melphalan | 14 | 18.5 | 18.5 |
| Pemetrexed Disodium | 22 | 17.5 | 17.5 |
| Brentuximab Vedotin | 6 | 17.4 | 17.4 |
| Bendamustine Hcl | 8 | 15.4 | 15.4 |
| Busulfan | 8 | 15.1 | 15.2 |
| Fingolimod Hcl | 39 | 14.0 | 14.0 |
| Bortezomib | 39 | 13.5 | 13.6 |
| Tenofovir Disoproxil Fumarate | 10 | 9.0 | 9.0 |